Veracyte reported $71K in Ordinary Share Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Agenus AGEN:US $ 2.67M 0.1M
Agilent A:US $ 3M 0M
Anika Therapeutics ANIK:US $ 0.14M 0M
Arrowhead Research ARWR:US $ 198K 1000
Biocept BIOC:US $ 0M 0M
Bruker BRKR:US $ 1.7M 0M
Exact Sciences EXAS:US $ 1.76M 0.02M
Heron Therapeutics HRTX:US $ 1.02M 0M
Illumina ILMN:US $ 2M 0M
Immunogen IMGN:US $ 2.2M 0M
Intrexon XON:US $ 0M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Laboratory Of America LH:US $ 8.5M 0M
Ligand Pharmaceuticals LGND:US $ 0.02M 0M
Myriad Genetics MYGN:US $ 0.8M 0M
Rigel Pharmaceuticals RIGL:US $ 0.17M 0M
Sangamo Biosciences SGMO:US $ 1.47M 0.01M
Siemens SIE:GR € 2550M 0M
Sonic Healthcare SHL:AU $ 4.14B 61.89M
Thermo Fisher Scientific TMO:US $ 440M 1M
Veracyte VCYT:US $ 0.07M 0M
Waters WAT:US $ 1.62M 0M